Inhibitors of the protein–protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line
Sign Up to like & getrecommendations! Published in 2020 at "Free Radical Research"
DOI: 10.1080/10715762.2020.1732955
Abstract: Abstract Resistance to anticancer agents has been an obstacle to developing therapeutics and reducing medical costs. Whereas sorafenib is used for the treatment of human hepatocellular carcinoma (HCC), resistance limits its efficacy. p62, a multifunctional… read more here.
Keywords: hepatocellular carcinoma; phosphorylated p62; huh cells; human hepatocellular ... See more keywords